Guest: Deepa Rangachari, MD Living with non-small cell lung cancer means living with a daily burden of symptoms like fatigue, decreased appetite, and shortness of breath. Dr. Deepa Rangachari, an oncologist at Harvard’s Beth Israel Deaconess Medical Center, expresses the importance of finding therapeutic strategies to help patients manage symptoms ..read more

Host: Jennifer Caudle, DO Guest: Deepa Rangachari, MD Survival rates for patients with non-small cell lung cancer have notably improved thanks to the development of targeted therapies and immunotherapies. With these recent advancements on the forefront, Dr. Deepa Rangachari joins Dr. Jennifer Caudle to discuss the KEYNOTE-189 study and how it could change our approach to treating patients with non-small cell lung cancer ..read more

Guest: Joshua Bauml, MD Tune in to hear medical oncologist Dr. Joshua Bauml from the University of Pennsylvania explain the difference between RET fusions and RET point mutations and how they each affect our treatment approach ..read more

Guest: Joshua Bauml, MD When a patient presents with non-small cell lung cancer, one question that comes up is: Could this patient have a RET fusion? Here to explore how we can answer that question is Dr. Joshua Bauml, medical oncologist and Assistant Professor at the University of Pennsylvania’s Perelman School of Medicine ..read more

Guest: Joshua Bauml, MD The COVID-19 pandemic has presented a unique and difficult problem for clinicians and patients alike. Here to share how he’s continuing treatment for his patients with non-small cell lung cancer in the era of COVID-19 is Dr. Joshua Bauml, a medical oncologist and Assistant Professor at the Perelman School of Medicine at the University of Pennsylvania ..read more

Guest: Fred R. Hirsch, MD, PhD Here to walk us through our current understanding of oncogene addiction and the resulting progress that’s been made in lung cancer treatment is Dr. Fred Hirsch from Mount Sinai ..read more

Guest: Deepa Rangachari, MD With newly approved therapies on the rise, the way we treat non-small cell lung cancer patients with a RET gene rearrangement may be evolving. That’s why it’s so important to test for RET mutations in patients with non-small cell lung cancer, as oncologist Dr. Deepa Rangachari explains ..read more

Guest: Deepa Rangachari, MD Communication is the key to guiding patients with non-small cell lung cancer through testing and treatment, but what exactly does that look like? Dr. Deepa Rangachari, an oncologist at the Beth Israel Deaconess Medical Center, shares strategies to help patients understand these processes and set realistic expectations ..read more

Host: Jennifer Caudle, DO Guest: Deepa Rangachari, MD Survival rates for patients with non-small cell lung cancer have notably improved thanks to the development of targeted therapies and immunotherapies. With these recent advancements on the forefront, Dr. Deepa Rangachari joins Dr. Jennifer Caudle to discuss the KEYNOTE-189 study and how it could change our approach to treating patients with non-small cell lung cancer ..read more

Guest: Deepa Rangachari, MD Living with non-small cell lung cancer means living with a daily burden of symptoms like fatigue, decreased appetite, and shortness of breath. Dr. Deepa Rangachari, an oncologist at Harvard’s Beth Israel Deaconess Medical Center, expresses the importance of finding therapeutic strategies to help patients manage symptoms ..read more